chr9-37521799-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_012166.3(FBXO10):āc.1970T>Gā(p.Leu657Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000443 in 1,604,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., cov: 32)
Exomes š: 0.000019 ( 0 hom. )
Consequence
FBXO10
NM_012166.3 missense
NM_012166.3 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 8.34
Genes affected
FBXO10 (HGNC:13589): (F-box protein 10) Members of the F-box protein family, such as FBXO10, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3112194).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO10 | NM_012166.3 | c.1970T>G | p.Leu657Arg | missense_variant | 8/11 | ENST00000432825.7 | NP_036298.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO10 | ENST00000432825.7 | c.1970T>G | p.Leu657Arg | missense_variant | 8/11 | 1 | NM_012166.3 | ENSP00000403802 | P1 | |
FBXO10 | ENST00000543968.5 | n.685T>G | non_coding_transcript_exon_variant | 6/6 | 3 | |||||
FBXO10 | ENST00000276960.7 | c.*177T>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/9 | 5 | ENSP00000276960 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152064Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
43
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000660 AC: 16AN: 242300Hom.: 0 AF XY: 0.0000379 AC XY: 5AN XY: 131798
GnomAD3 exomes
AF:
AC:
16
AN:
242300
Hom.:
AF XY:
AC XY:
5
AN XY:
131798
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000193 AC: 28AN: 1451940Hom.: 0 Cov.: 31 AF XY: 0.0000180 AC XY: 13AN XY: 722132
GnomAD4 exome
AF:
AC:
28
AN:
1451940
Hom.:
Cov.:
31
AF XY:
AC XY:
13
AN XY:
722132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000283 AC: 43AN: 152064Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74274
GnomAD4 genome
AF:
AC:
43
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
13
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.1970T>G (p.L657R) alteration is located in exon 8 (coding exon 7) of the FBXO10 gene. This alteration results from a T to G substitution at nucleotide position 1970, causing the leucine (L) at amino acid position 657 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at